Form 4 for BNTC Benitec Biopharma Inc.
Accepted 2025-11-10 00:00:00 ET · period of report 2025-11-07 · accession 0000899140-25-001256 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-11-10 | 2025-11-07 | BNTC | SUVRETTA CAPITAL MANAGEMENT, LLC | Dir, 10% | P - Purchase | $13.50 | +1.48M | 9.54M | +18% | +$20.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $0.0001 per share | 2025-11-07 | P | A | 751,111 | $13.50 | 1,819,812 | I See footnotes | — | — | (F3) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1. |
| 2 | Common | Common stock, par value $0.0001 per share | 2025-11-07 | P | A | 730,370 | $13.50 | 9,538,175 | I See footnotes | — | — | (F2) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1. |